About this episode

The episode discusses how AI and emerging technologies are transforming cancer care and decision-making in oncology.

Eric Lefkofsky, Founder and CEO of Tempus AI, joins Dr. Sanjay Juneja and Dr. Doug Flora to explore how artificial intelligence, real-world data, genomic sequencing, and emerging technologies like organoids are reshaping oncology. From reducing diagnostic errors to matching patients with more effective therapies, AI is transforming how clinicians make decisions and how researchers develop the next generation of treatments. The conversation examines why healthcare adoption has lagged behind technological progress, the growing role of patient-driven intelligence, and how connected data may help eliminate thousands of preventable cancer deaths each year. Eric also shares his vision for AI-powered clinical decision support, digital twins, drug development, and the future relationship between physicians and intelligent systems.

People in this episode

Hosts: Dr. Sanjay Juneja, Dr. Doug Flora

Guest: Eric Lefkofsky

Topics covered

• AI in oncology
• cancer care
• genomic sequencing
• clinical decision support
• patient-driven intelligence

Keywords

• artificial intelligence
• cancer treatment
• diagnostic errors
• real-world data
• drug development

Mentioned in this episode

Organizations: Tempus AI

More episodes of AI and Healthcare

• What If Every Patient Had a Digital Twin? Part 2 · June 16, 2026 · 31 min

Explore listener stats, chart rankings, contacts and more on the AI and Healthcare podcast page.